Age-Related Macular Degeneration Market Saw a Rise in 2018 | Novartis & Roche is Hot the Company has New Drugs Programs in its Pipeline – Forecast 2018-2023

Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally. Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets. The global market for age-related macular degenerations is expected to grow at a CAGR of approximately 7.3% during the forecast period.

Get Exclusive PDF Sample Report @ https://www.marketresearchfuture.com/sample_request/5736

Key Players for Age-Related Macular Degeneration Market:

Novartis International AG (Switzerland), Bayer AG (Germany), Acucela Inc. (U.S.), Neurotech Pharmaceuticals Inc. (U.S.), Ophthotech Corporation (U.S.), GlaxoSmithKline Plc (U.S.), Alimera sciences Inc. (U.S.), StemCell Inc. (Canada), F. Hoffmann-La Roche Ltd. (Switzerland), Regeneron Pharmaceutical Inc. (U.S.), Allergan Plc (Ireland), Adverum Biotechnologies Inc. (U.S.), Gilead Sciences Inc. (U.S.), Iconic Therapeutics Inc. (U.S.), Lpath Inc. (U.S.), OHR Pharmaceutical Inc. (U.S.), Bausch + Lomb (U.S.), Opthea Limited (Canada), PanOptica, Inc. (U.S.), Pfizer Inc. (U.S.), Neurotech Pharmaceuticals, Inc. (U.S.), Promedior, Inc. (U.S.), QLT Inc. (Canada), Quark (U.S.), Resolvyx Pharmaceuticals Inc. (U.S.), RXi Pharmaceuticals Inc. (U.S.), Sagent Pharmaceuticals, Inc. (U.S.), Alcon Vision Care (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Sanwa Kagaku Kenkyusho (Japan), and others.
Global Age-Related Macular Degeneration Market : Segmentation

Type
• Wet Age-Related Macular Degeneration (Wet AMD)/Neovascular
• Dry Age-Related Macular Degeneration (Dry AMD)/Non-Neovascular

Stages
• Intermediate Age-Related Macular Degeneration (AMD)
• Early Age-Related Macular Degeneration (AMD)
• Late Age-Related Macular Degeneration (AMD)

Age Group
• >75 years
• >60 years
• >40 years

Diagnosis & Treatment
• Treatment
• Diagnosis

Route of Administration
• Intravitreal
• Intravenous
• Others

End-User
• Hospitals & Clinics
• Diagnostic Centers
• Academic Research Institutes
• Others

By Region
• North America; The U.S., and Canada
• Europe; Germany, the UK, France, Spain, Italy, and Rest of Europe
• Asia Pacific (APAC); China, Japan, India and Rest of Asia Pacific
• The Middle East & Africa (MEA)
• South America

Intended Audience
• Medical Devices Companies
• Research and Development (R&D) Companies
• Pharmaceutical Companies
• Government Research Institutes
• Academic Institutes and Universities

Global Age-Related Macular Degeneration Market: Regional Analysis

Increased disease burden due to rising geriatric population is one of the major factors driving the growth of the global age-related macular degeneration (AMD) market. This market is expected to surpass a valuation of USD 2,200 Mn by the end of 2023. AMD remains a major cause of central visual loss, effecting close to 10% of people older than 65 years and over 25% of people older than 75 years globally. Increased awareness among people about the condition has influenced the AMD treatment global demand. At the same time, the arrival of off-patent blockbuster drugs is reflecting favorably on the market particularly in third-world countries. This has allowed small-scale drug manufactures to penetrate untapped markets.

Get Prime Discount on Report @ https://www.marketresearchfuture.com/check-discount/5736

Some Brief Table of Contents of Report

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants

TOC Continued…

Need more Information Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5736

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.